XML 129 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTRUCTURING, INTEGRATION AND OTHER COSTS (Tables)
 9 Months Ended
Sep. 30, 2013
B&L
  
Cost-rationalization and integration initiatives  
Schedule of major components of restructuring costs incurred in connection with Medicis acquisition-related initiatives
The following table summarizes the major components of restructuring costs incurred in connection with B&L Acquisition-related initiatives through September 30, 2013:
 
 
Employee Termination Costs
 
IPR&D
Termination
Costs
 
Contract
Termination,
Facility Closure
and Other Costs
 
 
 
Severance and
Related Benefits
 
Share-Based
Compensation(1)
 
 
 
Total
Balance, January 1, 2013
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Costs incurred and/or charged to expense
 
160,486

 
52,798

 
—

 
4,026

 
217,310

Cash payments
 
(27,174
)
 
(52,798
)
 
—

 
(1,571
)
 
(81,543
)
Non-cash adjustments
 
8,284

 
—

 
—

 
1,897

 
10,181

Balance, September 30, 2013
 
$
141,596

 
$
—

 
$
—

 
$
4,352

 
$
145,948

___________________________________
(1)
Relates to B&L’s previously cancelled performance-based options and the acceleration of unvested stock options for B&L employees as a result of the B&L Acquisition.
Medicis
  
Cost-rationalization and integration initiatives  
Schedule of major components of restructuring costs incurred in connection with Medicis acquisition-related initiatives
 
 
Employee Termination Costs
 
IPR&D
Termination
Costs
 
Contract
Termination,
Facility Closure
and Other Costs
 
 
 
Severance and
Related Benefits
 
Share-Based
Compensation(1)
 
 
 
Total
Balance, January 1, 2012
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Costs incurred and/or charged to expense
 
85,253

 
77,329

 
—

 
370

 
162,952

Cash payments
 
(77,975
)
 
(77,329
)
 
—

 
(5
)
 
(155,309
)
Non-cash adjustments
 
4,073

 
—

 
—

 
(162
)
 
3,911

Balance, December 31, 2012
 
11,351

 
—

 
—

 
203

 
11,554

Costs incurred and/or charged to expense
 
12,902

 
—

 
—

 
2,870

 
15,772

Cash payments
 
(21,573
)
 
—

 
—

 
(2,758
)
 
(24,331
)
Non-cash adjustments
 
151

 
—

 
—

 
(177
)
 
(26
)
Balance, March 31, 2013
 
2,831

 
—

 
—

 
138

 
2,969

Costs incurred and/or charged to expense
 
5,174

 
—

 
—

 
111

 
5,285

Cash payments
 
(7,407
)
 
—

 
—

 
(166
)
 
(7,573
)
Non-cash adjustments
 
513

 
—

 
—

 
—

 
513

Balance, June 30, 2013
 
1,111

 
—

 
—

 
83

 
1,194

Costs incurred and/or charged to expense
 
1,559

 
—

 
—

 
506

 
2,065

Cash payments
 
(1,860
)
 
—

 
—

 
(589
)
 
(2,449
)
Non-cash adjustments
 
(389
)
 
—

 
—

 
—

 
(389
)
Balance, September 30, 2013
 
$
421

 
$
—

 
$
—

 
$
—

 
$
421

____________________________________
(1)
Relates to the acceleration of unvested stock options, restricted stock awards, and share appreciation rights for Medicis employees that was triggered by the change in control.